Hannes Stockinger (Medical University of Vienna, Austria).
1 HUVECtert were grown in endothelial cell basal medium (EBM) supplemented with 10 % FCS, 100 U/mL penicillin, 100 µg/mL streptomycin, 1 % amphotericin B and EBM SingleQuots®, containing recombinant human epidermal growth factor, hydrocortisone, gentamicin sulfate, amphotericin B, and 0.4 % bovine brain extract. The stably transfected CHO-ARE LUC Nrf2-responsive reporter cell line was established and cultivated as reported previously. were washed with PBS and incubated in culture medium containing 10 μg/mL resazurin for 2 h. The detection step was performed as described above.
Crystal violet biomass staining
VSMC were seeded at a density of 5 × 10 3 cells/well in 96-well plates. After 24 h, cells were serumdeprived for 24 h to render them quiescent. Afterwards, plumericin or vehicle (0.1 % DMSO) was added as indicated, and after preincubation for 30 min, cells were stimulated with NBS (10 % final concentration) for 48 h. To determine the total biomass, cells were incubated in 100 μL crystal violet staining solution (0.5 % crystal violet, 20 % methanol) for 15 min and then thoroughly washed with ddH 2 O. After drying, 100 μL EtOH/sodium citrate solution were added (EtOH: 0.1M sodium citrate = 1:1) and the absorbance of the samples was measured at 595 nm in a 96-well plate reader (Tecan sunrise).
Antioxidant response element (ARE)-dependent luciferase (LUC) reporter gene assay
CHO-ARE-LUC cells were seeded into 96-well plates and treated with solvent (0.1 % DMSO) or the indicated concentrations of plumericin for 16 h before luciferase activity was assessed and normalized to fluorescence from co-transfected enhanced green fluorescent protein (EGFP) as described elsewhere.
4

Murine femoral artery cuff model
Male C57BL/6J mice at 8 to 12 weeks of age were subjected to surgical implantation of cuffs around the femoral arteries. The surgical procedure was performed as follows. Mice were anesthetized by intra-peritoneal injection of ketamine (100 mg/kg) and xylazine (10 mg/kg) and the left femoral artery of mice was exposed for 3 mm length from its surrounding tissue. Drug releasing cuffs, made from poly-(ε-caprolactone) and polyethylene glycol (PEG) (with or without addition of plumericin)
were placed to surround the artery. In case of the treatment, plumericin was pre-mixed with PEG and then this mixture was combined with the molten poly-(ε-caprolactone) (exposed to 70°C) in proportion of 1:4, for the final concentration of plumericin (165 µM) in the cuff material. We then shaped 2-3 mm long cuffs from this material to have a 0.5 mm inner diameter, and a 1 mm outer diameter. In control cuffs we omitted the plumericin supplementation. During the following 2 -3 days mice received Tramadol (10 -20 mg/kg, Grünenthal GmbH, Aachen, Germany) as analgesic drug. The arteries were harvested 28 d after placing of the cuff. To this, mice were anesthetized and subsequently perfused by cardiac puncture with EDTA-PBS (1.75 mg/mL). Upon perfusion, a 2 cm longitudinal incision was made in the internal side of the leg, and the cuffed femoral artery was 
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